Article references (26 references )


  1. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. Jama. 2001; 285(23): 2995-3002. PubMed | Google Scholar

  2. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology and prevention. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2005; 15(5): 727-746. PubMed | Google Scholar

  3. WHO. Cervical Cancer. Estimated Incidence, Mortality and Prevalence Worldwide in 2012.

  4. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases Report. Uganda. 2017.

  5. Banura C, Mirembe FM, Katahoire AR, Namujju PB, Mbidde EK. Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles. Infect Agent Cancer. 2012; 7(1): 24. PubMed | Google Scholar

  6. Twinomujuni C, Nuwaha F, Babirye JN. Understanding the Low level of cervical cancer screening in Masaka Uganda using the ASE model: a community-based survey. PloS One. 2015; 10(6): e0128498. PubMed | Google Scholar

  7. Rondy M, Van Lier A, Van de Kassteele J, Rust L, De Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine. 2010; 28(9): 2070-2075. PubMed | Google Scholar

  8. Program for Appropriate Technology in Health. Shaping a Strategy to Introduce HPV Vaccines in Uganda Formative Research Results from the HPV Vaccines: Evidence for Impact Project. 2009.

  9. Bennett S, Wood T, Liyanage W, Smith D. A simplified general method for cluster-sample surveys of health in developing countries. 1991. Google Scholar

  10. PATH, Child health and development Centre, Uganda National Expanded Program on Immunization. PATH, Child Health and Development Centre (CHDC), and the Uganda National Expanded Program on Immunization (UNEPI). HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda. Seattle: PATH; 2011.

  11. Bowyer HL, Marlow LA, Hibbitts S, Pollock KG, Waller J. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine. 2013; 31(7): 1051-1056. PubMed | Google Scholar

  12. Yar'Zever IS, Said IY. Knowledge and barriers in utilization of maternal health care services in Kano state, Northern Nigeria. Eur J Biol Med Sci Res. 2013; 1(1): 1-14. Google Scholar

  13. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination. BMC Public Health. 2008; 8: 368. PubMed | Google Scholar

  14. Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S et al. Population-level impact, herd immunity and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016; 1(1): e8-e17. PubMed | Google Scholar

  15. Stöcker P, Dehnert M, Schuster M, Wichmann O, Deleré Y. Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Hum Vaccines Immunother. 2013; 9(1): 74-82. PubMed | Google Scholar

  16. Uganda Demographic Health Survey, Uganda. 2011.

  17. Whelan AM. Lowering the age of consent: pushing back against the anti-vaccine movement. J Law Med Ethics. 2016; 44(3): 462-473. PubMed | Google Scholar

  18. Schaffer SJ, Fontanesi J, Rickert D, Grabenstein JD, Rothholz MC, Wang SA, et al. How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents. Pediatrics. 2008; 121(Supplement 1): S35-S45. PubMed | Google Scholar

  19. Ladner J, Besson M-H, Hampshire R, Tapert L, Chirenje M, Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health. 2012; 12: 370. PubMed | Google Scholar

  20. Donahue KL, Hendrix KS, Sturm LA, Zimet GD. Human papillomavirus vaccine initiation among 9-13-year-olds in the United States. Prev Med Rep. 2015; 2: 892-898. PubMed | Google Scholar

  21. WHO. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013. Google Scholar

  22. Patel V, Flisher AJ, Nikapota A, Malhotra S. Promoting child and adolescent mental health in low and middle income countries. J Child Psychol Psychiatry. 2008; 49(3): 313-334. PubMed | Google Scholar

  23. WHO. Comprehensive Cervical Cancer Control: a guide to essential practice. 2006. Google Scholar

  24. Small S, Patel D. Impact of HPV vaccine availability on uptake. J Nurse Pract. 2012; 8(1): 61-66. PubMed | Google Scholar

  25. Zapka JG, Lemon SC. Interventions for patients, providers and health care organizations. Cancer. 2004; 101(S5): 1165-1187. PubMed | Google Scholar

  26. Kessels S, Marshall H, Watson M, Braunack MA, Reuzel R, Tooher R, Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012; 30(24): 3546-3556. PubMed | Google Scholar